July 27, 2016 7:56 AM ET

Pharmaceuticals

Company Overview of Allergan, Inc.

Executive Profile

David E. I. Pyott

Chairman and Chief Executive Officer, Allergan, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 Board Members in 10 different organizations across 12 different industries.

See Board Relationships
63$17,785,957
As of Fiscal Year 2014

Background

Mr. David E. I. Pyott served as the Chief Executive Officer of Allergan, Inc. from January 1998 to March 2015. Mr. Pyott served as the President of Allergan, Inc. from January 1998 to February 1, 2006 and also from March 27, 2011 to June 2013. He served as the Chief Administrative Officer of Allergan, Inc. since August 1, 2010. Under his leadership, Allergan was transformed from a small eye care business with approximately $1 billion in sales to a global specialty pharmaceutical ...

Corporate Headquarters

400 Interpace Parkway
Parsippany, New Jersey 07054

United States

Phone: 862-261-7000
Fax: --

Board Members Memberships

Director and Member of Investment & Finance Committee
Director At Large
1998-Present
Chairman and Chief Executive Officer
1999-Present
Lead Independent Director, Chairman of Compensation & Executive Personnel Committee and Member of Governance & Social Responsibility Committee
2013-Present
Director
2015-Present
Independent Director and Member of Nominating & Corporate Governance Committee
2015-Present
Director
2015-Present
Chairman of the Board
2016-Present
Independent Director, Member of Corporate Governance & Nominating Committee and Member of Compensation Committee

Education

MA
University of Edinburgh in Scotland
MBA
London Business School

Other Affiliations

Annual Compensation

Salary$1,401,269
Total Annual Compensation$1,401,269

Stocks Options

All Other Compensation$52,136
Exercised Options$252,000
Exercised Options Value$21,915,760
Exercisable Options$2,265,200
Exercisable Options Value$343,106,749
Unexercisable Options$734,756
Unexercisable Options Value$79,105,693
Total Value of Options$444,128,201
Total Number of Options$3,251,956

Total Compensation

Total Annual Cash Compensation$3,674,205
Total Short Term Compensation$1,401,269
Other Long Term Compensation$52,136
Total Calculated Compensation$17,785,957
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Allergan, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.